Regional Control of Head and Neck Melanoma With Selective Neck Dissection

被引:12
|
作者
Geltzeiler, Mathew [1 ]
Monroe, Marcus [1 ]
Givi, Babak [1 ]
Vetto, John [2 ]
Andersen, Peter [1 ]
Gross, Neil [1 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Portland, OR 97239 USA
[2] Oregon Hlth & Sci Univ, Dept Surg, Div Surg Oncol, Portland, OR 97239 USA
关键词
LYMPH-NODE DISSECTION; MALIGNANT-MELANOMA; PROGNOSTIC-FACTORS; CUTANEOUS MELANOMA; LYMPHADENECTOMY; MANAGEMENT; EFFICACY; BIOPSY;
D O I
10.1001/jamaoto.2014.2056
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
IMPORTANCE Historically, patients with cervical metastases from melanoma of the head and neck were treated with a radical neck dissection. This study evaluates the efficacy of limiting the extent of lymphadenectomy in this high-risk population. OBJECTIVES To determine whether limiting the extent of lymphadenectomy for patients with biopsy-proven melanoma has a negative effect on regional control. Our hypothesis was that performing a more limited lymphadenectomy does not have a negative impact on regional control. DESIGN, SETTING, AND PARTICIPANTS A retrospective, single-cohort study was performed using a prospectively collected database of patients with head and neck melanoma with histopathologically positive lymph nodes after modified radical (MRND) or selective neck dissection (SNDs) performed at a high-volume, academic, tertiary care center. INTERVENTIONS Lymphadenectomy was performed as clinically indicated. MAIN OUTCOMES AND MEASURES Primary end points were regional recurrence and regional recurrence free survival. Univariable and multivariable analyses were conducted using multiple patient characteristics. RESULTS Forty-one patients underwent SND or MRND from 2001 through 2010. The median number of positive nodes was 1 (range, 1-16). Twenty-six patients (63%) received adjuvant radiation and 23 patients (56%) received adjuvant immunotherapy or chemotherapy. The median follow-up time was 17 months (range, 1-116 months). Regional control was achieved in 29 patients (71%). Median regional recurrence-free survival was 21 months (range, 1-116 months). Age (hazard ratio [HR], 1.13; 95% CI, 1.01-1.26), total number of nodes examined (HR, 1.05; 95% CI, 1.01-1.10), and number of sentinel lymph nodes examined (HR, 1.45; 95% CI, 1.01-2.09) were all significantly associated with increased recurrence-free survival. Tumor depth, extracapsular spread, number of nodes positive, prior SLNB, extent of lymphadenectomy, and adjuvant therapy were not significant. CONCLUSIONS AND RELEVANCE Limiting the extent of lymphadenectomy with frequent use of adjuvant radiation therapy is effective in achieving regional control of head and neck melanoma with cervical metastases.
引用
收藏
页码:1014 / 1018
页数:5
相关论文
共 50 条
  • [41] MELANOMA OF HEAD AND NECK
    CONLEY, JJ
    PACK, GT
    SURGERY GYNECOLOGY & OBSTETRICS, 1963, 116 (01): : 15 - &
  • [42] Head and neck melanoma
    Deskoulidi, P.
    Nikolaidou, T.
    Kydonakis, M.
    Diamantopoulos, P.
    Maltzaris, N.
    Agorogiannis, D.
    Benetatos, K.
    Kotrotsiou, M.
    Klonaris, C.
    Korogiannos, A.
    Koumakis, G.
    Gouveris, P.
    Stavrianos, S.
    Zarkadas, G.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 : 60 - 60
  • [43] Head and Neck Melanoma
    Larson, David L.
    Larson, Jeffrey D.
    CLINICS IN PLASTIC SURGERY, 2010, 37 (01) : 73 - +
  • [44] Melanoma of the Head and Neck
    Au, Alexander
    Ariyan, Stephan
    JOURNAL OF CRANIOFACIAL SURGERY, 2011, 22 (02) : 421 - 429
  • [45] MELANOMA OF THE HEAD AND NECK
    BRIELE, HA
    WALKER, MJ
    DASGUPTA, TK
    CLINICS IN PLASTIC SURGERY, 1985, 12 (03) : 495 - 504
  • [46] Melanoma of the head and neck
    Day T.A.
    Hornig J.D.
    Sharma A.K.
    Brescia F.
    Gillespie M.B.
    Lathers D.
    Current Treatment Options in Oncology, 2005, 6 (1) : 19 - 30
  • [47] MELANOMA OF HEAD AND NECK
    HARRIS, MN
    ROSES, DF
    CULLIFORD, AT
    GUMPORT, SL
    ANNALS OF SURGERY, 1975, 182 (01) : 86 - 91
  • [48] Assessment of Lymphatic Drainage Patterns and Implications for the Extent of Neck Dissection in Head and Neck Melanoma Patients
    Klop, W. Martin C.
    Veenstra, Hidde J.
    Vermeeren, Lenka
    Nieweg, Omgo E.
    Balm, Alfons J. M.
    Lohuis, Peter J. F. M.
    JOURNAL OF SURGICAL ONCOLOGY, 2011, 103 (08) : 756 - 760
  • [49] Should Neck Dissection Be Done After Positive Sentinel Node Biopsy for Head and Neck Melanoma?
    Chang, Brent A.
    Asarkar, Ameya A.
    Nagel, Thomas H.
    Nathan, Cherie-Ann O.
    LARYNGOSCOPE, 2022, 132 (11): : 2162 - 2163
  • [50] Efficacy of targeted chemoradiation and planned selective neck dissection to control bulky nodal disease in advanced head and neck cancer
    Robbins, KT
    Wong, FSH
    Kumar, P
    Hartsell, WF
    Vieira, F
    Mullins, B
    Niell, HB
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 1999, 125 (06) : 670 - 675